Cadence Navigates Challenges Associated with COVID-19
Cadence maintains stable production output through COVID-19 challenges
Staunton, Va. (March 23, 2020) – Cadence, Inc. has maintained stable production output as the company navigates through the challenges associated with COVID-19. Production at all of Cadence’s five facilities remains at full capacity with no significant supply disruptions. ...
Staunton, Va. (March 23, 2020) – Cadence, Inc. has maintained stable production output as the company navigates through the challenges associated with COVID-19. Production at all of Cadence’s five facilities remains at full capacity with no significant supply disruptions.
All Cadence employees remain safe with no known infection or exposure. The company has implemented a response team that meets daily to address the on-going situation. Extensive social distancing practices are also in place company-wide, as well as employee travel and visitor restrictions.
“Employee safety is our top priority while we continue to serve our customers and the patients who depend on the critical healthcare products that we provide. I am truly humbled by the effort, thoughtfulness, creativity, and empathy Cadence team members are exhibiting,” stated Alan Connor, CEO. “We stand ready to support our customers and continue to deliver critical medical products through this unprecedented time.”
About Cadence, Inc. – Cadence, Inc. is a contract manufacturing partner providing advanced products, technologies, and services to medical device, life science, industrial, and aerospace companies worldwide. Cadence employs approximately 575 people with its corporate headquarters in Staunton, Virginia and additional locations in Connecticut, Pennsylvania, Rhode Island and Wisconsin. For more information on Cadence, please visit our website at cadenceinc.com.
Beth Alltop, Marketing & Communications Specialist
540-248-2200 / [email protected]
Published by Cadence, Inc. on Apr 13, 2020